Andreas Halvorsen’s bluebird bio BLUE Stock Holding History

Andreas Halvorsen’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-47,521	Closed	-$52.7M	–	71
2015 Q3	$52.7M	Buy	+47,521	New	+$86.7M	0.2%	52

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Andreas Halvorsen's BLUE Position: Q4 2015 in Review

Andreas Halvorsen sold out of bluebird bio (BLUE) in Q4 2015, closing a stake of 47,521 shares — an estimated $52.7M sold.

Andreas Halvorsen first reported a position in BLUE in Q3 2015 and held it in 1 quarter. The position peaked at $52.7M in Q3 2015. 193 funds tracked by Wall St. Rank hold BLUE as of Q4 2015.

Andreas Halvorsen reported no remaining bluebird bio position as of Q4 2015 after selling out during the quarter.
Andreas Halvorsen sold 47,521 bluebird bio shares in Q4 2015, an estimated $52.7M.
Andreas Halvorsen first reported a position in bluebird bio in Q3 2015 and held it in 1 quarter.
Andreas Halvorsen's bluebird bio position peaked at $52.7M in Q3 2015.
193 funds tracked by Wall St. Rank held bluebird bio as of Q4 2015.

Based on Viking Global Investors's 13F filing for Q4 2015, filed 16 Feb 2016.